GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
Authors
Keywords
GOLPH3, 5-fluorouracil (5-FU), Colorectal cancer (CRC), Chemotherapy, Prognosis
Journal
Journal of Translational Medicine
Volume 12, Issue 1, Pages 15
Publisher
Springer Nature
Online
2014-01-21
DOI
10.1186/1479-5876-12-15
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians
- (2013) Amir Qaseem ANNALS OF INTERNAL MEDICINE
- XB130 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma
- (2012) Atsushi Shiozaki et al. ANNALS OF SURGICAL ONCOLOGY
- Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy
- (2012) D. Lu et al. CANCER RESEARCH
- Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor
- (2012) Z. Zeng et al. CLINICAL CANCER RESEARCH
- Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
- (2012) Xing Hua et al. Diagnostic Pathology
- Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis
- (2012) Jinxu Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
- (2012) Huan Li et al. Journal of Translational Medicine
- Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer
- (2012) Min Shi et al. PLoS One
- High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
- (2012) Jian-Hua Wang et al. PLoS One
- Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer
- (2012) Ben-Shun Hu et al. TUMOR BIOLOGY
- XB130, a Novel Adaptor Protein, Promotes Thyroid Tumor Growth
- (2011) Atsushi Shiozaki et al. AMERICAN JOURNAL OF PATHOLOGY
- Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
- (2011) Yvonne Tay et al. CELL
- Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study
- (2011) Xue-Yuan Li et al. JOURNAL OF NEURO-ONCOLOGY
- Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer
- (2011) Hai-Bo Han et al. JOURNAL OF PATHOLOGY
- ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
- (2010) H. Geng et al. CANCER RESEARCH
- Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3-Mediated Oncogenesis
- (2010) K. L. Scott et al. CLINICAL CANCER RESEARCH
- Adaptor protein XB130 is a Rac-controlled component of lamellipodia that regulates cell motility and invasion
- (2010) Monika Lodyga et al. JOURNAL OF CELL SCIENCE
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- GOLPH3 Bridges Phosphatidylinositol-4- Phosphate and Actomyosin to Stretch and Shape the Golgi to Promote Budding
- (2009) Holly C. Dippold et al. CELL
- GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
- (2009) Kenneth L. Scott et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now